Home / Central Data Catalog / FRESH-PEF2959-EN
central

Pragmatic pharmacoeconomic assessment of Sinovial® in the treatment of gonarthrosis

France, 2004 - 2005
Reference ID
FRESH-PEF2959-en
Producer(s)
Nicholas;MOORE
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
33
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Access policy
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF2959-en
    Title

    Pragmatic pharmacoeconomic assessment of Sinovial® in the treatment of gonarthrosis
    Abbreviation or Acronym

    EMES
    Country
    Name Country code
    France fr
    Kind of Data

    ['Clinical data','Socio-demographic data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Rheumatology health theme
    Osteoarthritis of knee cim-11
    Healthcare system determinants: Use of care health determinant
    Healthcare system determinants health determinant
    Keywords
    hyaluronic acid viscosupplementation gonarthrosis safety Sinovial® cost effectiveness pharmacoepidemiology cohort Department of Pharmacology Bordeaux

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patient agreed to participate in this study and having signed the consent form; Patient having had a first injection of Sinovial® between 01/01/2003 and 31/03/2003; Patient having never previously received viscosupplementation treatment; Patient aged 20 years and over; Patient affiliated to the general health insurance system for at least 12 months at the time of first injection","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Nicholas;MOORE
    Producers
    Name Role
    UNIVERSITE DE BORDEAUX sponsor
    Funding Agency/Sponsor
    Name
    IBSA PHARMA SAS

    Study authorization

    Agency
    Agency name
    CNIL
    CESREES

    Sampling

    Sample frame

    Unit Type

    ['Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2004-01-01 2005-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health care consumption and services

    Access policy

    Notes

    Ownership of study data is the subject of an agreement between the University of Bordeaux Segalen and the pharmaceutical company.

    Data Access

    Availability Status

    {"value":"To be defined","extLink":[]}

    Contacts

    Contacts
    Name Email
    Nicholas;MOORE nicholas.moore@u-bordeaux.fr
    Back to Catalog